Cybin to participate in the kcsa psychedelics virtual investor conference on april 28, 2022

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing “psychedelics to therapeutics™” is pleased to announce that doug drysdale, cybin's chief executive officer, will present at the kcsa psychedelics virtual investor conference at 11:00 a.m. et on thursday, april 28, 2022. this will be a live, interactive online event where investors are invited to ask the company questions in real-time. to participate
CYBN Ratings Summary
CYBN Quant Ranking